Ribozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts

Differentiation

Volumn 74, Issue 1, 2006, Pages 53-63

  Gomes Jr , Ronald R ^a,b   Joshi, Sonali S ^a   Farach Carson, Mary C ^a   Carson, Daniel D ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

BMP 2; Cartilage; Chondrogenesis; Heparan sulfate proteoglycan; Perlecan

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; PERLECAN; RIBOZYME;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CHONDROGENESIS; CONTROLLED STUDY; DENSITY; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; IN VITRO STUDY; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ANIMALIA; MURINAE;

EID: 33644959682     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1111/j.1432-0436.2005.00055.x     Document Type: Article

References (74)

1. Aberfeld DC. Hinterbuchner LP. et al 1965 Myotonia, dwarfism, diffuse bone disease and unusual ocular and facial abnormalities (a new syndrome) Brain 88 313 322
2. Ahrens M. Ankenbauer T. et al 1993 Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages DNA Cell Biol 12 871 880
3. Arikawa-Hirasawa E. Le AH. et al 2002 Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia Am J Hum Genet 70 1368 1375
4. Arikawa-Hirasawa E. Watanabe H. et al 1999 Perlecan is essential for cartilage and cephalic development Nat Genet 23 354 358
5. Arikawa-Hirasawa E. Wilcox WR. et al 2001a Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene Nat Genet 27 431 434
6. Arikawa-Hirasawa E. Wilcox WR. et al 2001b Dyssegmental dysplasia, Silverman-Handmaker type unexpected role of perlecan in cartilage development Am J Med Genet 106 254 257
7. Aulthouse AL. Solursh M. 1987 The detection of a precartilage, blastema-specific marker Dev Biol 120 377 384
8. Aviezer D. Hecht D. et al 1994 Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis Cell 79 1005 1013
9. Battaglia C. Mayer U. et al 1992 Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core Eur J Biochem 208 359 366
10. Brown JC. Sasaki T. et al 1997 The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans Eur J Biochem 250 39 46
11. Chimal-Monroy J. Diaz de Leon L. 1999 Expression of N-cadherin, N-CAM, fibronectin and tenascin is stimulated by TGF-beta1, beta2, beta3 and beta5 during the formation of precartilage condensations Int J Dev Biol 43 59 67
12. Costell M. Gustafsson E. et al 1999 Perlecan maintains the integrity of cartilage and some basement membranes J Cell Biol 147 1109 1122
13. Costell M. Mann K. et al 1997 Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides Eur J Biochem 243 115 121
14. Date T. Doiguchi Y. et al 2004 Bone morphogenetic protein-2 induces differentiation of multipotent C3H10T1/2 cells into osteoblasts, chondrocytes, and adipocytes in vivo and in vitro J Orthop Sci 9 503 508
15. DeLise AM. Fischer L. et al 2000 Cellular interactions and signaling in cartilage development Osteoarthritis Cartilage 8 309 334
16. Delise AM. Tuan RS. 2002 Analysis of N-cadherin function in limb mesenchymal chondrogenesis in vitro Dev Dyn 225 195 204
17. Denker AE. Haas AR. et al 1999 Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells i. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures Differentiation 64 67 76
18. Denker AE. Nicoll SB. et al 1995 Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-beta 1 Differentiation 59 25 34
19. Farach-Carson MC. Hecht JT. et al 2005 Heparan sulfate proteoglycans key players in cartilage biology Crit Rev Eukaryot Gene Expr 15 29 48
20. Fischer L. Boland G. et al 2002 Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells J Biol Chem 277 30870 30878
21. French MM. Gomes RR. Jr. et al 2002 Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I J Bone Miner Res 17 48 55
22. French MM. Smith SE. et al 1999 Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro J Cell Biol 145 1103 1115
23. Gohring W. Sasaki T. et al 1998 Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope Eur J Biochem 255 60 66
24. Gomes RR. Jr. Farach Carson MC. et al 2003 Perlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro Connect Tissue Res 44 Suppl 1 196 201
25. Govindraj P. West L. et al 2002 Isolation and identification of the major heparan sulfate proteoglycans in the developing bovine rib growth plate J Biol Chem 277 19461 19469
26. Haas AR. Tuan RS. 1999 Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells II. Stimulation by bone morphogenetic protein-2 requires modulation of N-cadherin expression and function Differentiation 64 77 89
27. Hassell JR. Robey PG. et al 1980 Isolation of a heparan sulfate-containing proteoglycan from basement membrane Proc Natl Acad Sci USA 77 4494 4498
28. Hogan BL. 1996 Bone morphogenetic proteins in development Curr Opin Genet Dev 6 432 438
29. Irie A. Habuchi H. et al 2003 Heparan sulfate is required for bone morphogenetic protein-7 signaling Biochem Biophys Res Commun 308 858 865
30. Kingsley DM. 1994 What do BMPs do in mammals? Clues from the mouse short-ear mutation Trends Genet 10 16 21
31. Ledbetter SR. Fisher LW. et al 1987 Domain structure of the basement membrane heparan sulfate proteoglycan Biochemistry 26 988 995
32. Ledbetter SR. Tyree B. et al 1985 Identification of the precursor protein to basement membrane heparan sulfate proteoglycans J Biol Chem 260 8106 8113
33. Lev R. Spicer SS. 1964 Specific staining of sulphate groups with alcian blue at low ph J Histochem Cytochem 12 309
34. Lillie R 1944 Various oil soluble dyes as fat stains in the supersaturated isopropanol technic Stain Technol 19 55 58
35. Lillie RD. Ashburn LL. 1943 Supersaturated solutions of fat stains in dilute isopropanol for demonstration of acute fatty degenerations not shown by herxheimer technic Arch Pathol 36 432 435
36. Liu R. Li W. et al 2000 Ribozyme ablation demonstrates that the cardiac subtype of the voltage-sensitive calcium channel is the molecular transducer of 1, 25-dihydroxyvitamin D(3)-stimulated calcium influx in osteoblastic cells J Biol Chem 275 8711 8718
37. Liu R. Rohe B. et al 2002 A rapid and simple nonradioactive method for in vitro testing of ribozyme activity Antisense Nucleic Acid Drug Dev 12 283 288
38. Mello MA. Tuan RS. 1999 High density micromass cultures of embryonic limb bud mesenchymal cells an in vitro model of endochondral skeletal development In Vitro Cell Dev Biol Anim 35 262 269
39. Milaire J. 1991 Lectin binding sites in developing mouse limb buds Anat Embryol (Berl) 184 479 488
40. Miller SA. Brown AJ. et al 2003 HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation Differentiation 71 322 336
41. Minina E. Kreschel C. et al 2002 Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation Dev Cell 3 439 449
42. Minina E. Wenzel HM. et al 2001 BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation Development 128 4523 4534
43. Miosge N. Simniok T. et al 2003 The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo J Histochem Cytochem 51 285 296
44. Modarresi R. Lafond T. et al 2005 N-cadherin mediated distribution of beta-catenin alters MAP kinase and BMP-2 signaling on chondrogenesis-related gene expression J Cell Biochem 95 53 63
45. Mongiat M. Sweeney SM. et al 2003 Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan J Biol Chem 278 4238 4249
46. Montgomery RA. Dietz HC. 1997 Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence Hum Mol Genet 6 519 525
47. Moy FJ. Safran M. et al 1997 Properly oriented heparin-decasaccharide- induced dimers are the biologically active form of basic fibroblast growth factor Biochemistry 36 4782 4791
48. Oberlender SA. Tuan RS. 1994a Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis Development 120 177 187
49. Oberlender SA. Tuan RS. 1994b Spatiotemporal profile of N-cadherin expression in the developing limb mesenchyme Cell Adhes Commun 2 521 537
50. Ohkawara B. Iemura S. et al 2002 Action range of BMP is defined by its N-terminal basic amino acid core Curr Biol 12 205 209
51. Ornitz DM. Leder P. 1992 Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3 J Biol Chem 267 16305 16311
52. Pantoliano MW. Horlick RA. et al 1994 Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization Biochemistry 33 10229 10248
53. Peng HB. Xie H. et al 1999 Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan J Cell Biol 145 911 921
54. Rapraeger AC. Krufka A. et al 1991 Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation Science 252 1705 1708
55. Rifkin DB. Moscatelli D. 1989 Recent developments in the cell biology of basic fibroblast growth factor J Cell Biol 109 1 6
56. Rossi M. Morita H. et al 2003 Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney Embo J 22 236 245
57. Ruoslahti E. Yamaguchi Y. 1991 Proteoglycans as modulators of growth factor activities Cell 64 867 869
58. Sasaki T. Costell M. et al 1998 Inhibition of glycosaminoglycan modification of perlecan domain I by site-directed mutagenesis changes protease sensitivity and laminin-1 binding activity FEBS Lett 435 169 172
59. Savore C. Zhang C. et al 2005 Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo Clin Exp Metastasis 22 377 390
60. Seghatoleslami MR. Roman-Blas JA. et al 2003 Progression of chondrogenesis in C3H10T1/2 cells is associated with prolonged and tight regulation of ERK1/2 J Cell Biochem 88 1129 1144
61. Seghatoleslami MR. Tuan RS. et al 2002 Cell density dependent regulation of AP-1 activity is important for chondrogenic differentiation of C3H10T1/2 mesenchymal cells J Cell Biochem 84 237 248
62. Spivak-Kroizman T. Lemmon MA. 1994 Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation Cell 79 1015 1024
63. Storm EE. Huynh TV. et al 1994 Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily Nature 368 639 643
64. SundarRaj N. Fite D. et al 1995 Perlecan is a component of cartilage matrix and promotes chondrocyte attachment J Cell Sci 108 Pt 7 2663 2672
65. Takada T. Katagiri T. et al 2003 Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins J Biol Chem 278 43229 43235
66. Talts JF. Andac Z. et al 1999 Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins Embo J 18 863 870
67. Taylor SM. Jones PA. 1979 Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine Cell 17 771 779
68. Travella JI. Forrester AW. et al 1994 Depression following myocardial infarction a one year longitudinal study Int J Psychiatry Med 24 357 369
69. Vlodavsky I. Miao HQ. et al 1996 Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor Cancer Metastasis Rev 15 177 186
70. Wang EA. Israel DI. et al 1993 Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells Growth Factors 9 57 71
71. Wreschner DH. McGuckin MA. et al 2002 Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins Protein Sci 11 698 706
72. Yang WD. Gomes RR. Jr. et al 2005 Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds Tissue Eng 11 76 89
73. Yayon A. Klagsbrun M. et al 1991 Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor Cell 64 841 848
74. Zimmermann B. Thies M. 1984 Alterations of lectin binding during chondrogenesis of mouse limb buds Histochemistry 81 353 361